Essential Partners »

Monte Rosa Therapeutics shares owned by Essential Partners

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Essential Partners from 13F filings

Historical chart of Essential Partners investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by Essential Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by Essential Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $214k 13k 16.45
2025-12-31 $206k 13k 15.68
2025-09-30 $97k 13k 7.41
2025-06-30 $59k 13k 4.51

More positions owned by Essential Partners

Sprott Gold Convert to Physical Cef (PHYS)
Comfort Sys Usa Stock (FIX)
Nvidia Corporation Stock (NVDA)
Schwab Fundamental Int'l Broad Etf (FNDF)
iShares S&P 500 Etf (IVV)
Schwab Fundamental U.S. Broad Etf (FNDB)
Vanguard Short-Term USTS Etf (VGSH)
General Mtrs Stock (GM)
Ge Aerospace Stock (GE)
Merck & Co Stock (MRK)
Technipfmc Stock (FTI)
Ge Vernova Stock (GEV)
Teradyne Stock (TER)
Incyte Corp Stock (INCY)
Pnc Finl Svcs Group Stock (PNC)

View all positions for Essential Partners

Top funds holding Monte Rosa Therapeutics

NEA Management Company
BlackRock
TCG Crossover Management
BVF
Baker Bros. Advisors
Suvretta Capital Management
Vestal Point Capital
Vanguard Group
Braidwell
Versant Venture Management
Vanguard Capital Management
State Street Corporation
Aisling Capital Management
Geode Capital Management
American Century Companies

View all funds holding Monte Rosa Therapeutics